Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016, Article ID 9076813, 4 pages
http://dx.doi.org/10.1155/2016/9076813
Case Report

Multiple Renal Abscesses due to ESBL Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Causing Acute Pyelonephritis and Bacteremia: A Case Report with a Good Outcome (No Drainage Required)

1Internal Medicine Department, International Medical Center (IMC) Hospital, Jeddah, Saudi Arabia
2Radiology Department, IMC Hospital, Jeddah, Saudi Arabia
3Emergency Medicine Department, IMC Hospital, Jeddah, Saudi Arabia

Received 28 August 2016; Accepted 2 November 2016

Academic Editor: Peter Olumese

Copyright © 2016 Abdalla Khalil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ben-Ami, J. Rodríguez-Baño, H. Arslan et al., “A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing enterobacteriaceae in nonhospitalized patients,” Clinical Infectious Diseases, vol. 49, no. 5, pp. 682–690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Melzer and I. Petersen, “Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli,” Journal of Infection, vol. 55, no. 3, pp. 254–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Tumbarello, T. Spanu, M. Sanguinetti et al., “Bloodstream infections caused by extended-spectrum-β-lactamase- producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 2, pp. 498–504, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Zarb, B. Coignard, J. Griskeviciene et al., “The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use,” Euro Surveillance, vol. 17, no. 46, 2012. View at Google Scholar · View at Scopus
  5. S. S. Magill, J. R. Edwards, W. Bamberg et al., “Multistate point-prevalence survey of health care-associated infections,” New England Journal of Medicine, vol. 370, no. 13, pp. 1198–1208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Castanheira, S. E. Farrell, K. M. Krause, R. N. Jones, and H. S. Sader, “Contemporary diversity of β-lactamases among enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 2, pp. 833–838, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Morrissey, M. Hackel, R. Badal, S. Bouchillon, S. Hawser, and D. Biedenbach, “A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011,” Pharmaceuticals, vol. 6, no. 11, pp. 1335–1346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Gales, M. Castanheira, R. N. Jones, and H. S. Sader, “Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010),” Diagnostic Microbiology and Infectious Disease, vol. 73, no. 4, pp. 354–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Yezli, A. M. Shibl, D. M. Livermore, and Z. A. Memish, “Prevalence and antimicrobial resistance among Gram-Negative pathogens in Saudi Arabia,” Journal of Chemotherapy, vol. 26, no. 5, pp. 257–272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kandeel, “Prevalence and risk factors of extended-spectrum β-lactamases producing Enterobacteriaceae in a general hospital in Saudi Arabia,” Journal of Microbiology and Infectious Diseases, vol. 4, no. 2, pp. 50–54, 2014. View at Publisher · View at Google Scholar
  11. F. E. Al-Otaibi and E. E. Bukhari, “Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia,” Saudi Medical Journal, vol. 34, no. 2, pp. 171–176, 2013. View at Google Scholar · View at Scopus
  12. M. K. Lim, K. W. Kim, H. K. Lee, Y. D. Woen, and Y. S. Kim, “Multiple renal abscesses caused by extended spectrum beta lactamase producing Escherichia coli,” Korean Journal of Nephrology, vol. 24, no. 3, pp. 460–463, 2005 (Korean). View at Google Scholar